Marktgröße und Marktanteil von Small Interfering RNA (siRNA)-Therapeutika bis 2025 – 2031
Small Interfering RNA (siRNA) Therapeutics Market Report Analysis
Small Interfering RNA (siRNA) Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Horizon Discovery
- GlaxoSmithKline
- Sirna Therapeutics, Inc.
- Alnylam Pharmaceuticals
- Sanofi Genzyme
- Olix Pharmaceuticals
- Silence Therapeutics AG
- Calando Pharmaceuticals
- Arbutus Biopharma Corp
Regional Overview
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Mittlerer Osten und Afrika
Market Segmentation
By Indikation
- Onkologie
- Herz-Kreislauf-Erkrankungen
- Atemwegserkrankungen
- neurodegenerative Erkrankungen
- Infektionskrankheiten
- Sonstige
By Arten
- Liposomenbasierte systemische Therapie
- Nanopartikelbasierte systemische Therapie
- Sonstige
By Endbenutzer
- Diagnoselabor
- Forschungs- und akademische Labore
By Geographie
- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
Get Free Sample For